SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
05-Jun-20 4:05 PM View: | Deciphera Pharmaceuticals, ... (NA) | 05-Jun-20 | Option Exercise | 5,635 | $25.73 | $144,989.00 | 100% 0 to 5.63K | |
05-Jun-20 4:05 PM View: | Deciphera Pharmaceuticals, ... (NA) | 05-Jun-20 | Market Option Sale | 5,635 | $55.90 | $314,999.00 | (100%) 5.63K to 0 | |
05-Jun-20 4:05 PM View: | Deciphera Pharmaceuticals, ... (NA) | 03-Jun-20 | Option Exercise | 6,365 | $25.73 | $163,771.00 | 100% 0 to 6.37K | (10%) |
05-Jun-20 4:05 PM View: | Deciphera Pharmaceuticals, ... (NA) | 03-Jun-20 | Market Option Sale | 6,365 | $59.14 | $376,450.00 | (100%) 6.37K to 0 | |
28-Jan-20 4:13 PM View: | Deciphera Pharmaceuticals, ... (NA) | 24-Jan-20 | Conversion | 25,000 | $3.95 | $98,750.00 | 100% 0 to 25.0K | |
28-Jan-20 4:13 PM View: | Deciphera Pharmaceuticals, ... (NA) | 24-Jan-20 | Market Sale (Planned) | 25,000 | $66.13 | $1,653,330.00 | (100%) 25.0K to 0 | |
26-Jul-16 5:10 PM View: | Larimar Therapeutics, Inc. (LRMR) | 26-Jul-16 | Market Purchase | 8,200 | $3.15 | $25,830.00 | 71% 11.59K to 19.79K | 290% |
26-Jul-16 5:10 PM View: | Larimar Therapeutics, Inc. (LRMR) | 25-Jul-16 | Market Purchase | 7,800 | $3.08 | $24,031.80 | 206% 3.79K to 11.59K | 299% |
24-Apr-09 5:22 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 22-Apr-09 | Option Exercise | 25,000 | $0.95 | $23,750.00 | 3828% 0.65K to 25.65K | |
24-Apr-09 5:22 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 22-Apr-09 | Market Option Sale (Planned) | 25,000 | $17.63 | $440,745.00 | (97%) 25.65K to 0.65K | (328%) |
26-Oct-07 4:24 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Oct-07 | Option Exercise | 20,000 | $0.95 | $19,000.00 | 1869% 1.07K to 21.07K | |
26-Oct-07 4:24 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Oct-07 | Market Option Sale | 13,710 | $31.86 | $436,836.00 | (65%) 21.07K to 7.36K | (137%) |
26-Oct-07 4:24 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Oct-07 | Market Option Sale (Planned) | 100 | $31.54 | $3,154.00 | (1%) 7.36K to 7.26K | (139%) |
26-Oct-07 4:24 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Oct-07 | Market Sale | 5,990 | $32.18 | $192,729.00 | (83%) 7.26K to 1.27K | (135%) |
26-Oct-07 4:24 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Oct-07 | Market Sale (Planned) | 200 | $32.06 | $6,412.00 | (16%) 1.27K to 1.07K | (136%) |